208 related articles for article (PubMed ID: 31928533)
1. Involvement of collagen XVII in pluripotency gene expression and metabolic reprogramming of lung cancer stem cells.
Hsu HS; Liu CC; Lin JH; Hsu TW; Hsu JW; Li AF; Hung SC
J Biomed Sci; 2020 Jan; 27(1):5. PubMed ID: 31928533
[TBL] [Abstract][Full Text] [Related]
2. High metabolic rate and stem cell characteristics of esophageal cancer stem-like cells depend on the Hsp27-AKT-HK2 pathway.
Liu CC; Chou KT; Hsu JW; Lin JH; Hsu TW; Yen DH; Hung SC; Hsu HS
Int J Cancer; 2019 Oct; 145(8):2144-2156. PubMed ID: 30920655
[TBL] [Abstract][Full Text] [Related]
3. Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.
Udoh K; Parte S; Carter K; Mack A; Kakar SS
Stem Cell Rev Rep; 2019 Aug; 15(4):601-611. PubMed ID: 30835047
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
5. Low-folate stress reprograms cancer stem cell-like potentials and bioenergetics metabolism through activation of mTOR signaling pathway to promote in vitro invasion and in vivo tumorigenicity of lung cancers.
Chen WJ; Huang RS
J Nutr Biochem; 2018 Mar; 53():28-38. PubMed ID: 29190547
[TBL] [Abstract][Full Text] [Related]
6. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
7. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
[TBL] [Abstract][Full Text] [Related]
8. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
Wang J; Shao F; Yang Y; Wang W; Yang X; Li R; Cheng H; Sun S; Feng X; Gao Y; He J; Lu Z
Cancer Commun (Lond); 2022 Oct; 42(10):1008-1027. PubMed ID: 35975322
[TBL] [Abstract][Full Text] [Related]
9. Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells.
Liu CC; Lin SP; Hsu HS; Yang SH; Lin CH; Yang MH; Hung MC; Hung SC
Nat Commun; 2016 Jun; 7():11798. PubMed ID: 27306323
[TBL] [Abstract][Full Text] [Related]
10. HSPA1L Enhances Cancer Stem Cell-Like Properties by Activating IGF1Rβ and Regulating β-Catenin Transcription.
Choi SI; Lee JH; Kim RK; Jung U; Kahm YJ; Cho EW; Kim IG
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971893
[TBL] [Abstract][Full Text] [Related]
11. Expression of anti-aging type-XVII collagen (COL17A1/BP180) in hair follicle-associated pluripotent (HAP) stem cells during differentiation.
Shirai K; Obara K; Tohgi N; Yamazaki A; Aki R; Hamada Y; Arakawa N; Singh SR; Hoffman RM; Amoh Y
Tissue Cell; 2019 Aug; 59():33-38. PubMed ID: 31383286
[TBL] [Abstract][Full Text] [Related]
12. Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer.
Liu CC; Lin JH; Hsu TW; Hsu JW; Chang JW; Su K; Hsu HS; Hung SC
Oncotarget; 2018 Jan; 9(2):1656-1672. PubMed ID: 29416721
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics analysis reveals Oct4 overexpression drives metabolic reprogramming and enhanced glycolysis and pentose phosphate pathway in lung adenocarcinoma cells.
Tang Y; Zhu L; Chen H; Meng S
Biomed Chromatogr; 2022 Jun; 36(6):e5367. PubMed ID: 35274324
[TBL] [Abstract][Full Text] [Related]
15. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
[TBL] [Abstract][Full Text] [Related]
16. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane Inhibits the Acquisition of Tobacco Smoke-Induced Lung Cancer Stem Cell-Like Properties
Xie C; Zhu J; Jiang Y; Chen J; Wang X; Geng S; Wu J; Zhong C; Li X; Meng Z
Theranostics; 2019; 9(16):4827-4840. PubMed ID: 31367260
[No Abstract] [Full Text] [Related]
19. Autophagic homeostasis is required for the pluripotency of cancer stem cells.
Sharif T; Martell E; Dai C; Kennedy BE; Murphy P; Clements DR; Kim Y; Lee PW; Gujar SA
Autophagy; 2017 Feb; 13(2):264-284. PubMed ID: 27929731
[TBL] [Abstract][Full Text] [Related]
20. Role of OCT4 in cancer stem-like cells and chemotherapy resistance.
Mohiuddin IS; Wei SJ; Kang MH
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165432. PubMed ID: 30904611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
